(-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels
Yasemin Akbulut1, Hannah J Gaunt, Katsuhiko Muraki
1Max-Planck-Institut für Molekulare Physiologie, Otto-Hahn-Strasse 11, 44227 Dortmund (Germany); Technische Universität Dortmund, Fakultät Chemie, Lehrbereich Chemische Biologie, Otto-Hahn-Strasse 6, 44227 Dortmund (Germany).
Abstract:
Current therapies for common types of cancer such as renal cell cancer are often ineffective and unspecific, and novel pharmacological targets and approaches are in high demand. Here we show the unexpected possibility for the rapid and selective killing of renal cancer cells through activation of calcium-permeable nonselective transient receptor potential canonical (TRPC) calcium channels by the sesquiterpene (-)-englerin A. This compound was found to be a highly efficient, fast-acting, potent, selective, and direct stimulator of TRPC4 and TRPC5 channels. TRPC4/5 activation through a high-affinity extracellular (-)-englerin A binding site may open up novel opportunities for drug discovery aimed at renal cancer.
Insights
A novel compound, (-)-englerin A, rapidly and selectively kills renal cancer cells by activating specific calcium channels (TRPC4/5). This discovery offers new avenues for developing targeted renal cancer therapies.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Current renal cell cancer therapies lack specificity and efficacy.
- There is a critical need for novel pharmacological targets and treatment strategies.
Purpose of the Study:
- To investigate the potential of sesquiterpene (-)-englerin A in targeting renal cancer cells.
- To explore the mechanism of action of (-)-englerin A on calcium channels.
Main Methods:
- Utilized (-)-englerin A, a sesquiterpene compound.
- Investigated the activation of calcium-permeable nonselective transient receptor potential canonical (TRPC) channels, specifically TRPC4 and TRPC5.
- Assessed the compound's effect on renal cancer cell viability.
Main Results:
- (-)-Englerin A demonstrated rapid and selective killing of renal cancer cells.
- The compound acts as a potent, selective, and direct stimulator of TRPC4 and TRPC5 channels.
- A high-affinity extracellular binding site for (-)-englerin A on TRPC4/5 was identified.
Conclusions:
- Activation of TRPC4/5 channels by (-)-englerin A presents a novel approach for renal cancer treatment.
- This mechanism offers promising opportunities for future drug discovery in renal cancer therapy.
More Related Videos
13:40Live Cell Calcium Imaging Combined with siRNA Mediated Gene Silencing Identifies Ca2+ Leak Channels in the ER Membrane and their Regulatory Mechanisms
Published on: July 7, 2011
12:09Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
Related Concept Videos
G-Protein Gated Ion Channels
Sensory...
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
